Cancer treatment reviews

Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].

Pub Date : 2024-12-21 DOI: 10.1016/j.ctrv.2024.102866 Eugenia Cella, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan, Agnese Losurdo, Marta Maccari, Giulia Cerretti, Tamara Ius, Giuseppe Minniti, Ahmed Idbaih, Nader Sanai, Michael Weller, Matthias Preusser, Matteo Simonelli, Giuseppe Lombardi

Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis.

Pub Date : 2024-12-19 DOI: 10.1016/j.ctrv.2024.102865 Francesco Schettini, Sabrina Nucera, Tomás Pascual, Olga Martínez-Sáez, Rodrigo Sánchez-Bayona, Benedetta Conte, Giuseppe Buono, Matteo Lambertini, Kevin Punie, Juan Miguel Cejalvo, Grazia Arpino, Paolo Vigneri, Daniele Generali, Eva Ciruelos, Javier Cortés, Alessandra Gennari, Montserrat Muñoz, Maria J Vidal Losada, Sara M Tolaney, Aleix Prat, Guillermo Villacampa

Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma.

Pub Date : 2024-12-03 DOI: 10.1016/j.ctrv.2024.102864 Xin Tian, Hongyan Zhang, Yiman Han, Baoru Gu, Zhenyong Zhang